This study confirmed that heavy training shifted the cardiac autonomic balance toward a predominance of the sympathetic over the parasympathetic drive. When recorded during the night, heart rate variability appeared to be a better tool than resting heart rate to evaluate cumulated physical fatigue, as it magnified the induced changes in autonomic nervous system activity. These results could be of interest for optimizing individual training profiles.

In order to assess the relative contribution of aerobic processes to running velocity (v), 27 male athletes were selected on the basis of their middle-distance performances over 800, 1500, 3000 or 5000 m, during the 1987 track season. To be selected for study, the average running velocity (v) corresponding to their performances had to be superior to 90% of the best French v of the season. Maximum O2 consumption (VO2max) and energy cost of running (C) had been measured within the 2 months preceding the track season, which, together with oxygen consumption at rest (VO2rest) allowed us to calculate the maximal v that could be sustained under aerobic conditions: vamax = (VO2max - VO2rest) x C-1. The treadmill running v corresponding to a blood lactate of 4 mmol.l-1 (vla4), was also calculated. In the whole group, C was significantly related to height (r = -0.43; P less than 0.03). Neither C nor VO2max (with, in this case, the exception of the 3000 m athletes) were correlated to v. On the other hand, vamax was significantly correlated to v over distances longer than 800 m. These v were also correlated to vla4. However vla4 occurred at 87.5% SD 3.3% of vamax, this relationship was interpreted as being an expression of the correlation between vamax and v. Calculation of vamax provided a useful means of analysing the performances. At the level of achievement studied, v sustained over 3000 m corresponded to vamax.(ABSTRACT TRUNCATED AT 250 WORDS)

Since the pioneering studies of the 1960s, heart rate variability (HRV) has become an increasingly used non-invasive tool for examining cardiac autonomic functions and dysfunctions in various populations and conditions. Many calculation methods have been developed to address these issues, each with their strengths and weaknesses. Although, its interpretation may remain difficult, this technique provides, from a non-invasive approach, reliable physiological information that was previously inaccessible, in many fields including death and health prediction, training and overtraining, cardiac and respiratory rehabilitation, sleep-disordered breathing, large cohort follow-ups, children's autonomic status, anesthesia, or neurophysiological studies. In this context, we developed HRVanalysis, a software to analyse HRV, used and improved for over 20 years and, thus, designed to meet laboratory requirements. The main strength of HRVanalysis is its wide application scope. In addition to standard analysis over short and long periods of RR intervals, the software allows time-frequency analysis using wavelet transform as well as analysis of autonomic nervous system status on surrounding scored events and on preselected labeled areas. Moreover, the interface is designed for easy study of large cohorts, including batch mode signal processing to avoid running repetitive operations. Results are displayed as figures or saved in TXT files directly employable in statistical softwares. Recordings can arise from RR or EKG files of different types such as cardiofrequencemeters, holters EKG, polygraphs, and data acquisition systems. HRVanalysis can be downloaded freely from the Web page at: https://anslabtools.univ-st-etienne.fr HRVanalysis is meticulously maintained and developed for in-house laboratory use. In this article, after a brief description of the context, we present an overall view of HRV analysis and we describe the methodological approach of the different techniques provided by the software.

Performance is correlated with nocturnal ANS activity at an individual level. The decrease in ANS activity during intensive training is correlated with the loss in performance, and the rebound in ANS activity during tapering tracks with the gain in performance. Interestingly, the speed of the rebound during the tapering period was quite different between swimmers. ANS activity measurement may be useful to design and control individual training periods and to optimize the duration of tapering.

The impact of undiagnosed SRBD on cognitive function appeared quite limited in a generally older healthy population, and only slightly affected severe cases. The implication of undiagnosed SRBD on the cognitive impairment in elderly subjects remains hypothetical and needs to be prospectively studied.

To investigate the different ways of assessing the running velocity at which maximal oxygen uptake (VO2max) occurs, or maximal aerobic velocity (vamax), 32 well-trained runners (8 female and 24 male) were studied. The vamax and the running velocity corresponding to a blood lactate concentration of 4 mmol.l-1 (vla4) were measured during a progressive treadmill session. Within the week preceding or following the treadmill measurement the subjects completed a Université de Montreal Track-Test (UMTT). The velocity corresponding to the last stage of this test (vUMTT) was slightly higher than vamax: 6.08 m.s-1, SD 0.41, vs 6.01 m.s-1, SD 0.44 (P less than 0.03) but these two velocities were strongly correlated (r = 0.92, P less than 0.001). The heart rate values corresponding to these velocities were similar and well correlated (r = 0.79, P less than 0.01); the corresponding blood lactate values had similar mean values: 10.5 mmol.l-1, SD 2.7 vs 11.8 mmol.l-1, SD 2.5, but were not correlated. Both vamax and vUMTT correlated well with the best performance sustained over 1500 m during the season. These results suggest that the UMTT provides a value of vamax as accurately as a treadmill measurement and that either could be used to measure the running velocity corresponding to VO2max. The v1a4 was 86.6%, SD 2.6 of vamax; these two velocities correlated strongly. Thus, in well trained runners, v1a4, when measured with a well-defined procedure, corresponds to a constant fraction of vamax and depends then on VO2max and the energy cost of running.

Presence of undiagnosed RLS is higher in healthy elderly participants without previously diagnosed sleep disorders, affecting women more often than men. The presence of RLS increased the risk of anxiety and mood disorders and predispose to preclinical cognitive decline independently of anxiety, mood disorders, duration and quality of sleep, and medication.

The relationships between anaerobic glycolysis and the average velocity (v) sustained during running were studied in 17 top level athletes (11 males and 6 females). A blood sample was obtained within 10 min of the completion of major competitions over 400 m, 800 m and 1500 m and the blood lactate concentration [la]b was measured. In both male and female athletes [la]b was related to the relative performance, as expressed as a percentage of the athlete's best v of the season. Over 400 m, r = 0.85 (P less than 0.01) and r = 0.80 (P less than 0.05) in males and females, respectively. Over 800 m, the corresponding values were r = 0.76 (P less than 0.01) and r = 0.91 (P less than 0.01). In male runners [la]b was correlated to v: r = 0.89 (P less than 0.01) and r = 0.71 (P less than 0.02) over 400 m and 800 m, respectively. No relationship to relative performance or v was obtained over 1500 m. Energy expenditure during competition running was estimated in male runners from the [la]b values. This estimate was based mainly on the assumption that a 1 mmol.1-1 increase in [la]b corresponded to the energy produced by the utilization of 3.30 ml.O kg-1. The energy cost of running was estimated, by dividing the estimated total energy expenditure by the race distance, at 0.211 ml.kg-1.min-1 over 800 m and 0.274 ml.kg-1.m-1 over 400 m.(ABSTRACT TRUNCATED AT 250 WORDS)